APP and Alzheimer disease: Another study suggests that the depletion of B cells using anti-CD20 antibodies or B cell-deficient mice resulted in the amelioration of AD in three different mouse models of AD that included 3×TgAD, APP/PS1, and 5×FAD mice [60].